Company intelligence
Healthy Longevity Medicine Society
International peak professional medical society in the field of longevity medicine
About Healthy Longevity Medicine Society
The Healthy Longevity Medicine Society (HLMS) was established in August 2022 to build a clinically credible framework and platform for longevity medicine that promotes the highest standards of interdisciplinary collaboration in the field. The HLMS is governed by a Council of elected members representing different geographical locations and sectors. The HLMS aims to educate, foster research and professional development, set recommendations and guidelines, and coordinate activities across the various domains of longevity medicine.
Verified activity
Signals from Healthy Longevity Medicine Society
5 published signals
Research & Knowledge
Healthy Longevity Medicine Society published an article titled Healthspan Medicine: A Collaborative Model for Addressing Aging and Healthspan in Clinical Practice in the Science special issue Toward Healthy Longevity: Integrating Biology, AI, and Clinical Innovation.
Reported by Evelyne Bischof, MD, PhD
Research & Knowledge
Healthy Longevity Medicine Society published a study showing that an AI-generated drug called rentosertib, originally developed with AI to treat a deadly lung disease, showed that patients taking it appeared biologically younger according to six different protein-based aging clocks.
Reported by Evelyne Bischof, MD, PhD
Research & Knowledge
Healthy Longevity Medicine Society published a study in Nature Biotechnology by Alex Zhavoronkov and Vadim Gladyshev showing that a Phase 2a trial in IPF patients receiving the novel TNIK inhibitor rentosertib showed a reduction in predicted biological age with six independent proteomic aging clocks.
Reported by Evelyne Bischof, MD, PhD
Presence & Recognition
Healthy Longevity Medicine Society speaker Evelyne Bischof returned as a speaker to the Longevity Investors Conference 2026 in Gstaad, Switzerland.
Reported by Evelyne Bischof, MD, PhD
Presence & Recognition
Healthy Longevity Medicine Society is attending a scientific discussion on the potential of the GKI at the intersection of metabolic health, mitochondrial function, and chronic disease.
Reported by Evelyne Bischof, MD, PhD